Dev

Mitochondrial dysfunction in the pathogenesis of Parkinson’s disease: identifying novel disease mechanisms and designing treatments Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Parkinson’s disease – from genetic risk factors to molecular mechanisms and clinical phenotypes Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

The role of the blood-brain barrier in Alzheimers disease function Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

HOME-based ICT solutions FOR the independent living of people with DEMentia and their caregivers Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Protein kinase inhibitors for dementia Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Mitochondrial dysfunction in the pathogenesis of Parkinsons disease: elucidating disease mechanisms and identifying therapeutic targets Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Public dementia care in terms of equal services – family, local and multiethnic perspectives Investments > €500k Norway Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

Development of a Novel F18-PET tracer for early diagnosis of Alzheimers Dementia Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Inflammation, Amyloid and Atrophy in The Aging Brain: The Borders between Healthy Brain Aging and Neurodegeneration Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Young Onset Dementia – the difficult diagnosis and the stressful life for the whole family Investments > €500k Norway Alzheimer’s disease & other dementias 2016